Entrada Therapeutics
TRDA
#6018
Rank
A$1.14 B
Marketcap
$30.59
Share price
-0.80%
Change (1 day)
19.09%
Change (1 year)

Entrada Therapeutics (TRDA) - Cash on Hand

Cash on Hand as of September 2024 : A$0.69 Billion

According to Entrada Therapeutics's latest financial reports the company has A$0.69 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Entrada Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.51 B86.29%
2022-12-31A$0.27 B-30.93%
2021-12-31A$0.40 B690.65%
2020-12-31A$50.77 M111.07%
2019-12-31A$24.05 M